Journal of Nanomaterials / 2018 / Article / Tab 3

Research Article

Evaluation of Long-Term Inflammatory Responses after Implantation of a Novel Fully Bioabsorbable Scaffold Composed of Poly-L-lactic Acid and Amorphous Calcium Phosphate Nanoparticles

Table 3

Coronary artery serum levels of ALT, AST, UR, CR, and CRP.

Preimplant1 month6 months12 months24 months

ALT (U/L)
 PLLA49.17 ± 12.4661.67 ± 19.9865.33 ± 18.9669.17 ± 17.5764.00 ± 17.80
 PLLA/ACP51.17 ± 15.4358.00 ± 26.8071.67 ± 21.6072.33 ± 24.0458.83 ± 17.75
value0.810.790.600.800.63
AST (U/L)
 PLLA38.33 ± 8.5549.50 ± 18.9256.83 ± 16.8256.50 ± 21.8454.33 ± 17.11
 PLLA/ACP38.00 ± 8.6043.67 ± 18.8560.33 ± 26.4545.50 ± 28.2351.33 ± 24.23
value0.950.600.790.470.81
UR (mmol/l)
 PLLA5.13 ± 1.326.22 ± 1.055.77 ± 3.196.83 ± 3.026.80 ± 3.07
 PLLA/ACP4.50 ± 1.445.72 ± 1.726.38 ± 2.986.28 ± 2.997.25 ± 2.88
value0.450.560.740.760.80
CR (μmol/l)
 PLLA78.83 ± 13.78118.67 ± 25.5692.17 ± 23.0389.50 ± 28.89113.17 ± 24.59
 PLLA/ACP84.00 ± 15.21105.83 ± 23.92104.33 ± 29.57102.33 ± 29.84100.50 ± 26.49
value0.550.390.440.470.41
LDH (U/l)
 PLLA177.33 ± 66.01300.67 ± 157.83217.50 ± 81.45193.33 ± 88.80199.83 ± 120.87
 PLLA/ACP179.50 ± 46.47243.67 ± 107.07201.83 ± 35.89232.33 ± 104.32278.83 ± 111.24
value0.950.480.680.500.27
CRP (mg/l)
 PLLA0.93 ± 0.471.64 ± 0.861.33 ± 0.531.71 ± 0.481.10 ± 0.51
 PLLA/ACP1.13 ± 0.441.75 ± 0.651.62 ± 0.411.28 ± 0.431.29 ± 0.64
values0.470.790.330.140.58

Notes: Data are presented as mean ± standard deviation. values: the PLLA/ACP group compared with the PLLA group.